Cluster tC2 includes almost exclusively “glioblastomas, IDH-wildtype” and has undergone only minor changes—namely, a few cases have moved into the category of WHO grade 4 “astrocytoma, IDH-mutant”. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).